# A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

> **NCT05749861** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 65 (actual)

## Conditions studied

- Hypertension and Dyslipidemia

## Interventions

- **DRUG:** CKD-348(5)
- **DRUG:** CKD-828, D097, D337

## Key facts

- **NCT ID:** NCT05749861
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-22
- **Primary completion:** 2023-06-07
- **Final completion:** 2023-07-18
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05749861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05749861, "A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05749861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*